(Q46857211)

25 December 2017

title

Pramipexole protects against H2O2-induced PC12 cell death (English)

1 reference

25 December 2017

1 reference

Yoshiko Fujita

1

1 reference

25 December 2017

Yuki Izawa

2

1 reference

25 December 2017

Nermin Ali

3

1 reference

25 December 2017

Yasuhisa Kanematsu

4

1 reference

25 December 2017

Koichiro Tsuchiya

5

1 reference

25 December 2017

Shuichi Hamano

6

1 reference

25 December 2017

Toshiaki Tamaki

7

1 reference

25 December 2017

Masanori Yoshizumi

8

1 reference

25 December 2017

publication date

16 December 2005

1 reference

25 December 2017

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

25 December 2017

volume

372

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

257-266

1 reference

25 December 2017

Role of oxidants in ischemic brain damage

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0025-2

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0025-2

Reactive oxygen species and programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0025-2

Neuroprotection and dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-005-0025-2

Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species

21 January 2018

1 reference

12 December 2020

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease

1 reference

12 December 2020

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

1 reference

12 December 2020

Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis

1 reference

12 December 2020

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

1 reference

12 December 2020

DNA damage by oxygen-derived species Its mechanism and measurement in mammalian systems

1 reference

12 December 2020

Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra

1 reference

12 December 2020

Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

1 reference

12 December 2020

The stress-activated protein kinase pathways

1 reference

12 December 2020

Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

12 December 2020

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease

1 reference

12 December 2020

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

12 December 2020

The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study

1 reference

12 December 2020

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma

1 reference

12 December 2020

Mitochondria and apoptosis

1 reference

12 December 2020

Reactive oxygen species and the central nervous system

1 reference

12 December 2020

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

1 reference

12 December 2020

JNK activation by tetrahydrobiopterin: implication for Parkinson's disease

1 reference

12 December 2020

The fight of viruses against apoptosis

1 reference

12 December 2020

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

12 December 2020

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

1 reference

12 December 2020

Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-terminal protein kinase pathway

1 reference

12 December 2020

Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation.

1 reference

12 December 2020

Oxidative stress in neurodegeneration: cause or consequence?

1 reference

12 December 2020

Clinical pharmacology of dopamine agonists in Parkinson's disease

1 reference

12 December 2020

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.

1 reference

12 December 2020

The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress.

1 reference

12 December 2020

Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human

1 reference

12 December 2020

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

1 reference

12 December 2020

Induction of apoptosis in HEp-2 cells by infection with herpes simplex virus type 2.

1 reference

12 December 2020

Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines

1 reference

12 December 2020

Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells

1 reference

12 December 2020

Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms

1 reference

12 December 2020

Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway

1 reference

12 December 2020

The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease

1 reference

12 December 2020

Understanding cell death in Parkinson's disease

1 reference

12 December 2020

An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons

1 reference

12 December 2020

Dopamine agonists and neuroprotection in Parkinson's disease

1 reference

12 December 2020

c-Jun and the transcriptional control of neuronal apoptosis

1 reference

12 December 2020

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

12 December 2020

Sounding the alarm: protein kinase cascades activated by stress and inflammation

1 reference

12 December 2020

Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress.

1 reference

12 December 2020

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

1 reference

12 December 2020

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

1 reference

12 December 2020

Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide

1 reference

12 December 2020

Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells

1 reference

12 December 2020

10.1007/S00210-005-0025-2

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017